Pyridostigmine for Diabetic Constipation: Four Trial Checks

If constipation persists despite treatment, bring a record of bowel movements and everything you have tried to your appointment. Ask what testing or treatment should come next. These four checks help put a proposed pyridostigmine prescription in context.

Who entered?

A blinded trial included 30 adults with diabetes and chronic constipation, including 22 women. All completed treatment: 16 received pyridostigmine, 14 placebo. Evacuation disorders and significant kidney or cardiorespiratory disease were excluded. Dose escalation preceded seven days at a stable dose.¹

What moved faster?

One primary imaging outcome, 24-hour colonic geometric center, favored pyridostigmine: treatment means 2.45 versus 1.84 (adjusted P<0.01). The 1–5 scale indicates faster transit at higher values. The other primary outcome, ascending-colon emptying, was not significant after baseline adjustment.¹

Did bowel movements improve?

Complete spontaneous bowel movements rose from 2.1 to 4.0 weekly versus 2.1 to 3.1 with placebo; the adjusted comparison was not significant. Stool frequency, consistency and ease of passage favored the drug. This small, short NIH-funded study cannot establish lasting benefit.¹

Where does it fit?

The AGA’s January 2026 advice suggests off-label agents such as pyridostigmine for refractory constipation after available over-the-counter and FDA-approved treatments have failed. It also advises checking secondary causes and evaluating pelvic floor function, with biofeedback when indicated. Most patients should have anorectal manometry with balloon-expulsion testing before being labeled refractory. Ask whether medicines, an evacuation problem or slow transit could be contributing, and which standard treatments have been adequately tried.²

US conventional-tablet labeling lists myasthenia gravis, not constipation. Mechanical intestinal or urinary obstruction is a contraindication; asthma requires caution. Kidney disease can require lower dosing. Adverse effects include diarrhea, cramps, sweating, salivation and muscle weakness. Excess dosing can cause a cholinergic crisis with dangerous breathing-muscle weakness. Severe weakness or trouble breathing needs urgent care. Review all medicines and pregnancy or breastfeeding plans with the prescriber; do not copy the trial’s escalation schedule.³

Bloated by Dinner offers a “Visit Script”: bring your bowel-pattern log, list medicines and supplements, and ask what has been ruled out and what comes next. Describe incomplete emptying or straining alongside how often you go, so the appointment covers more than a movement count.